Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2026)
Indivior Pharmaceuticals' Net Margin came in at 35.57% for Q2 2026, up 29.61 percentage points from 5.96% a year earlier and up 7.49 percentage points from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Indivior Pharmaceuticals reported Net Margin of 26.65%, up 17.45 percentage points year-over-year; for FY2025, it was 16.95%, up 16.36 percentage points from FY2024.
- Net Margin carries a four-year change of -8.97 percentage points (FY2021 to FY2025).
- Going back by year, Net Margin was 0.59% in FY2024 (+12.12 pp), -11.53% in FY2023 (-6.87 pp), -4.66% in FY2022 (-30.58 pp) and 25.92% in FY2021.
- The Q2 2026 figure represents the highest quarterly Net Margin in data going back to Q1 2024.
- Year-over-year, Net Margin has increased for five consecutive quarters, with an average year-over-year change of +17.05 percentage points over the last six quarters.
- Business Quant data shows INDV's Net Margin at 28.08% (Q1 2026), 28.49% (Q4 2025) and 13.38% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 35.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.57% |
| Mar 31, 2026 | 28.08% |
| Dec 31, 2025 | 28.49% |
| Sep 30, 2025 | 13.38% |
| Jun 30, 2025 | 5.96% |
| Mar 31, 2025 | 17.67% |
| Dec 31, 2024 | 7.02% |
| Sep 30, 2024 | 7.17% |
| Jun 30, 2024 | -32.44% |
| Mar 31, 2024 | 21.48% |
API Access
Indivior Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();